Alternatives to Tymlos If You Can't Fill Your Prescription

Tymlos (abaloparatide) is one of the most effective medications for building new bone in people with severe osteoporosis. But access barriers — from specialty pharmacy requirements and insurance prior authorization to the high cost of this brand-only drug — can leave some patients without a prescription they need.

The good news: there are several other FDA-approved osteoporosis medications your doctor may consider. In this guide, we'll walk through the best alternatives to Tymlos in 2026, how they work, and what to discuss with your provider.

Why You Might Need an Alternative to Tymlos

Patients may need an alternative to Tymlos for several reasons:

Insurance denial or unaffordable cost without savings programs

Inability to access a specialty pharmacy in your area

Contraindications such as Paget's disease, bone metastases, or history of skeletal radiation

Allergy to abaloparatide or any component of Tymlos

Completion of the maximum 2-year lifetime limit on Tymlos (or cumulative PTH analog therapy)

Alternative #1: Teriparatide (Forteo / Generic Abaloparatide-analog)

Teriparatide is the closest alternative to Tymlos. It is also a parathyroid hormone (PTH) analog that builds new bone through daily subcutaneous injection. Like Tymlos, teriparatide is limited to 2 years of lifetime use.

The key difference: FDA-approved generic teriparatide injections are now available from manufacturers like Teva. Generic teriparatide can cost as low as $1,146/month with a GoodRx coupon — significantly less than the brand Forteo or Tymlos list price.

Approved for: Postmenopausal women, men, and patients on long-term glucocorticoid therapy

Key difference from Tymlos: Slightly higher rate of hypercalcemia; may not reduce nonvertebral fractures as effectively as Tymlos based on ACTIVE trial data

Cost advantage: Generic versions available, significantly cheaper than Tymlos

Alternative #2: Romosozumab (Evenity)

Romosozumab (Evenity) is a newer medication with a unique dual mechanism — it both builds new bone and reduces bone breakdown simultaneously. It's given as two monthly subcutaneous injections administered in-office for 12 months.

Important warning: Romosozumab carries a boxed warning for cardiovascular events (heart attack and stroke). It should not be used in patients who have had a heart attack or stroke within the past year.

Approved for: Postmenopausal women at high risk of fracture

Key advantage: Monthly in-office injections (no self-injection required), only 12 months of treatment

Not for: Patients with recent heart attack, stroke, or high cardiovascular risk

Alternative #3: Denosumab (Prolia)

Denosumab (Prolia) works differently from Tymlos — instead of building new bone, it slows bone breakdown by blocking a protein called RANKL. It's given as a subcutaneous injection every 6 months, typically in a doctor's office.

Critical note: Denosumab must not be discontinued without transitioning to a bisphosphonate. Stopping denosumab abruptly can cause rapid bone loss and multiple vertebral fractures (rebound effect).

Approved for: Postmenopausal women, men with osteoporosis, and patients with certain cancer-related bone loss

Mechanism: Antiresorptive only (slows breakdown, does not actively build bone like Tymlos)

Alternative #4: Bisphosphonates (Alendronate, Risedronate, Zoledronic Acid)

Bisphosphonates are the first-line, most cost-effective option for most osteoporosis patients. Generic alendronate (Fosamax) costs as little as $10–$30 for a monthly supply. Options include:

Alendronate (Fosamax): Weekly oral pill; most widely prescribed

Risedronate (Actonel): Weekly or monthly oral pill

Zoledronic acid (Reclast): Annual IV infusion; ideal for patients who can't tolerate oral medications

Bisphosphonates are antiresorptive — they slow bone breakdown rather than building new bone. They are often used after completing a course of Tymlos or teriparatide to maintain and extend the bone density gains.

How to Choose: Which Alternative Is Right for You?

The best alternative depends on your specific situation. Here's a quick guide:

Need anabolic (bone-building) therapy: Teriparatide or romosozumab are the closest alternatives

Cost is the primary concern: Generic bisphosphonates are the most affordable at ~$10–$30/month

Fewer injections preferred: Denosumab (every 6 months) or zoledronic acid (once yearly) require less frequent dosing

History of cardiovascular events: Avoid romosozumab; discuss teriparatide or bisphosphonates with your doctor

Always Talk to Your Doctor Before Switching

Never change your osteoporosis medication without consulting your prescriber. Your doctor can review your bone density T-scores, fracture history, kidney function, and cardiovascular health to recommend the safest and most effective alternative. And if you want to keep trying to find Tymlos first, medfinder can help you locate pharmacies that can fill your prescription — before you give up on it.

Also see our Tymlos shortage update for 2026 for the latest on availability and what to expect.